References
- Akbarzadeh A, Mikaeili H, Zarghami N, et al. (2012). Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomed 7:511–26
- Brannon-Peppas L, Blanchette JO. (2004). Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649–59
- Danhier F, Feron O, Préat V. (2010). To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46
- Elnakat H, Ratnam M. (2004). Distribution, functionality and gene regulation of folate receptor isoforms: Implications in targeted therapy. Adv Drug Deliv Rev 56:1067–84
- Fields RJ, Cheng CJ, Quijano E, et al. (2012). Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery. J Control Release 164:41–8
- Gao X, Wang B, Wei X, et al. (2013). Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer. Int J Nanomed 8:971–82
- Jia Y, Yuan M, Yuan H, et al. (2012). Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. Int J Nanomed 7:1697–708
- Jiang Z, Sun C, Yin Z, et al. (2012). Comparison of two kinds of nanomedicine for targeted gene therapy: Premodified or postmodified gene delivery systems. Int J Nanomed 7:2019–31
- Kong F, Zhou F, Ge L, et al. (2012). Mannosylated liposomes for targeted gene delivery. Int J Nanomed 7:1079–89
- Li P, Liu D, Miao L, et al. (2012). A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomed 7:925–39
- Liu C, Yu W, Chen Z, et al. (2011). Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis. J Control Release 151:162–75
- Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. (2002). Polyethylene glycol-dia-cyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 19:1424–9
- Men K, Liu W, Li L, et al. (2012). Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Nanoscale 4:6425–33
- Morris VB, Sharma CP. (2010). Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector. Int J Pharm 389:176–85
- Parker N, Turk MJ, Westrick E, et al. (2005). Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338:284–93
- Paulos CM, Reddy JA, Leamon CP, et al. (2004). Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol Pharmacol 66:1406–14
- Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60
- Watanabe K, Kaneko M, Maitani Y. (2012). Functional coating of liposomes using a folate-polymer conjugate to target folate receptors. Int J Nanomed 7:3679–88
- Wang BL, Gao X, Men K, et al. (2012a). Treating acute cystitis with biodegradable micelle-encapsulated quercetin. Int J Nanomed 7:2239–47
- Wang W, Zhou F, Ge L, et al. (2012b). Transferrin–PEG–PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomed 7:2513–22
- Wu G, Zhou F, Ge L, et al. (2012). Novel mannan–PEG–PE modified bioadhesive PLGA nanoparticles for targeted gene delivery. J Nanomater 2012:981670
- Wu M, Gunning W, Ratnam M. (1999). Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 8:775–82
- Yamada A, Taniguchi Y, Kawano K, et al. (2008). Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res 14:8161–8